Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Belief Biomed
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
March 23, 2026
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved in Macao, China
March 19, 2026